Francesco Siccardi
Chief Executive Officer
Replay available
Medacta Group S.A. (LSE: 0A05) Q4 2025 earnings conference call, held 2026-03-13. Replay captured from the company's public earnings webcast.

Chief Executive Officer
Chief Financial Officer
Analyst at Berenberg
Analyst at Stifel
Analyst at Octavian
Analyst at Zurich Cantonal Bank
Analyst at UBS
Speaker 1: Good afternoon. Speaker 1: This is the CORSCO conference operator. Speaker 1: Welcome and thank you for joining the MED-ACTA full year 2025 Speaker 1: results conference call. Speaker 1: As a reminder, all participants are in listen-only mode. Speaker 1: After the presentation, there will be an opportunity Speaker 1: to ask questions. Speaker 1: Should anyone need assistance Speaker 1: during the conference call, they may signal an operator by pressing star and 0 on their telephone. Speaker 1: At this time, I would like to turn the conference over to Mr. Francesco Siccardi, Speaker 1: CEO of Medacta. Speaker 1: Please go ahead, sir. Speaker 2: Thank you. Thank you very much and good afternoon or good morning. Speaker 2: Welcome to Medacta Full Year 2025 Speaker 2: results conference call. Speaker 2: The slides of today's presentation Speaker 2: can be found on the Medacta investor relations website Speaker 2: along with the media release. Speaker 2: I would like to remind all participants that the presentation includes Speaker 2: forward-looking statements which are subject to risk and uncertainties. Speaker 2: Listeners and readers are therefore encouraged to refer to the disclaimer Speaker 2: on slide 2 of today's presentation. Speaker 2: So after those remarks, I will now Speaker 2: turn to slide number 4 of Speaker 2: the presentation with the highlights Speaker 2: of today's publication. Speaker 2: We did a report already, our revenues Speaker 2: 684 Speaker 2: million with 18.5% Speaker 2: growth in cost and currency. Speaker 2: The EBITDA Speaker 2: margin in cost and currency Speaker 2: is 29% Speaker 2: and 27.9 Speaker 2: in euro with an increase of Speaker 2: 19.1% Speaker 2: year over year. Speaker 2: Medactors Speaker 2: net profit Speaker 2: ...